Kabisch S, Hajir J, Sukhobaevskaia V, Weickert M, Pfeiffer A
Int J Mol Sci. 2025; 26(5).
PMID: 40076626
PMC: 11900212.
DOI: 10.3390/ijms26052000.
Gan Y, Yuan Z, Weng J, Huang M, Li T, Wu Y
BMC Biol. 2025; 23(1):61.
PMID: 40016751
PMC: 11866714.
DOI: 10.1186/s12915-025-02170-6.
Profir M, Enache R, Rosu O, Pavelescu L, Cretoiu S, Gaspar B
Biomedicines. 2025; 13(1).
PMID: 39857762
PMC: 11762760.
DOI: 10.3390/biomedicines13010179.
Han Z, Fu J, Gong A, Ren W
Sci China Life Sci. 2025; .
PMID: 39825207
DOI: 10.1007/s11427-024-2789-1.
Andrei C, Mihai D, Nitulescu G, Nitulescu G, Zanfirescu A
Int J Mol Sci. 2025; 25(24.
PMID: 39769455
PMC: 11727697.
DOI: 10.3390/ijms252413695.
Metabolic Reprograming of Macrophages: A New Direction in Traditional Chinese Medicine for Treating Liver Failure.
Zhang J, Li N, Hu X
J Immunol Res. 2025; 2024():5891381.
PMID: 39741958
PMC: 11688140.
DOI: 10.1155/jimr/5891381.
Metabolic Reprogramming of Macrophages by Biomimetic Melatonin-Loaded Liposomes Effectively Attenuates Acute Gouty Arthritis in a Mouse Model.
Ma C, Jiang Y, Xiang Y, Li C, Xie X, Zhang Y
Adv Sci (Weinh). 2024; 12(7):e2410107.
PMID: 39717013
PMC: 11831490.
DOI: 10.1002/advs.202410107.
RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype.
Naseri B, Alipour S, Masoumi J, Hatami-Sadr A, Vaysi E, Hemmat N
Immunol Res. 2024; 73(1):21.
PMID: 39699830
DOI: 10.1007/s12026-024-09572-8.
Engineering bacteria for cancer immunotherapy by inhibiting IDO activity and reprogramming CD8+ T cell response.
Wang H, Xu F, Yao C, Dai H, Xu J, Wu B
Proc Natl Acad Sci U S A. 2024; 121(52):e2412070121.
PMID: 39693352
PMC: 11670085.
DOI: 10.1073/pnas.2412070121.
Multimodal single-cell profiling reveals neuronal vulnerability and pathological cell states in focal cortical dysplasia.
Galvao I, Lemoine M, Messias L, Araujo P, Geraldis J, Yasuda C
iScience. 2024; 27(12):111337.
PMID: 39640563
PMC: 11617397.
DOI: 10.1016/j.isci.2024.111337.
The microbiota: a key regulator of health, productivity, and reproductive success in mammals.
Khan I, Nassar N, Chang H, Khan S, Cheng M, Wang Z
Front Microbiol. 2024; 15:1480811.
PMID: 39633815
PMC: 11616035.
DOI: 10.3389/fmicb.2024.1480811.
mTOR inhibitors as potential therapeutics for endometriosis: a narrative review.
Nakamura A, Tanaka Y, Amano T, Takebayashi A, Takahashi A, Hanada T
Mol Hum Reprod. 2024; 30(12).
PMID: 39579091
PMC: 11634386.
DOI: 10.1093/molehr/gaae041.
Staphylococcus epidermidis alters macrophage polarization and phagocytic uptake by extracellular DNA release in vitro.
Weisselberg S, Both A, Failla A, Huang J, Linder S, Ohnezeit D
NPJ Biofilms Microbiomes. 2024; 10(1):131.
PMID: 39567551
PMC: 11579364.
DOI: 10.1038/s41522-024-00604-7.
Renal Inflammation, Oxidative Stress, and Metabolic Abnormalities During the Initial Stages of Hypertension in Spontaneously Hypertensive Rats.
Wojtacha P, Bogdanska-Chomczyk E, Majewski M, Obremski K, Majewski M, Kozlowska A
Cells. 2024; 13(21.
PMID: 39513878
PMC: 11545559.
DOI: 10.3390/cells13211771.
Systemic lupus erythematosus: pathogenesis and targeted therapy.
Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z
Mol Biomed. 2024; 5(1):54.
PMID: 39472388
PMC: 11522254.
DOI: 10.1186/s43556-024-00217-8.
The Role of mTOR in Infection.
Patel A, Nguyen L, Shea C, Singh S, Venketaraman V
Biomedicines. 2024; 12(10).
PMID: 39457551
PMC: 11505195.
DOI: 10.3390/biomedicines12102238.
A Paradoxical AKT: Exploring the Promise and Challenges of PI3K/AKT/mTOR Targeted Therapies.
Parkman G, Holmen S
J Cancer Immunol (Wilmington). 2024; 6(3):92-99.
PMID: 39381117
PMC: 11460539.
DOI: 10.33696/cancerimmunol.6.089.
Low protein diet protects the liver from Salmonella Typhimurium-mediated injury by modulating the mTOR/autophagy axis in macrophages.
Wojtowicz E, Hampton K, Moreno-Gonzalez M, Utting C, Lan Y, Ruiz P
Commun Biol. 2024; 7(1):1219.
PMID: 39349819
PMC: 11444042.
DOI: 10.1038/s42003-024-06932-w.
Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner.
Singh S, Braun C, Carroll-Portillo A, Coffman C, Lin H
Microorganisms. 2024; 12(9).
PMID: 39338507
PMC: 11434237.
DOI: 10.3390/microorganisms12091833.
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV.
Henrich T, Bosch R, Godfrey C, Mar H, Nair A, Keefer M
Cell Rep Med. 2024; 5(10):101745.
PMID: 39321793
PMC: 11513808.
DOI: 10.1016/j.xcrm.2024.101745.